General Information of the Compound
Compound ID
CP0507740
Compound Name
4-((1,3,4-thiadiazol-2-ylthio)methyl)-7-hydroxy-2H-chromen-2-one
    Show/Hide
Structure
Formula
C12H8N2O3S2
Molecular Weight
292.341
Canonical SMILES
Oc1ccc2c(CSc3nncs3)cc(=O)oc2c1
    Show/Hide
InChI
InChI=1S/C12H8N2O3S2/c15-8-1-2-9-7(3-11(16)17-10(9)4-8)5-18-12-14-13-6-19-12/h1-4,6,15H,5H2
    Show/Hide
InChIKey
RPGXEUPVDMCBEA-UHFFFAOYSA-N
Physicochemical Property
logP
2.6424
Rotatable Bonds
3
Heavy Atom Count
19
Polar Areas
76.22
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 8302749
SID: 57299513
ChEMBL ID
CHEMBL589155
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03321, 17-beta-hydroxysteroid dehydrogenase type 3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
IC50 = 200 nM
   TI
   LI
   LO
   TS